Canandaigua National Bank & Trust CO Astrazeneca PLC Transaction History
Canandaigua National Bank & Trust CO
- $1.04 Billion
- Q3 2024
A detailed history of Canandaigua National Bank & Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 14,913 shares of AZN stock, worth $977,845. This represents 0.11% of its overall portfolio holdings.
Number of Shares
14,913
Previous 15,740
5.25%
Holding current value
$977,845
Previous $1.23 Million
5.3%
% of portfolio
0.11%
Previous 0.13%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.12 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.75 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.41 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.25 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...